BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34279421)

  • 1. The Fruits of
    Lin LT; Shi YC; Choong CY; Tai CJ
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both endogenous and exogenous miR-139-5p inhibit Fusobacterium nucleatum-related colorectal cancer development.
    Zhao Y; Tao Q; Li S; Zheng P; Liu J; Liang X
    Eur J Pharmacol; 2020 Dec; 888():173459. PubMed ID: 32768506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
    Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
    J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
    Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
    World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
    Guo P; Tian Z; Kong X; Yang L; Shan X; Dong B; Ding X; Jing X; Jiang C; Jiang N; Yu Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):202. PubMed ID: 32993749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum.
    Liu J; Hsieh CL; Gelincik O; Devolder B; Sei S; Zhang S; Lipkin SM; Chang YF
    J Proteomics; 2019 Mar; 195():125-137. PubMed ID: 30634002
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Lin LT; Uen WC; Choong CY; Shi YC; Lee BH; Tai CJ; Tai CJ
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31163662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
    Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
    mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer.
    Wang N; Fang JY
    Trends Microbiol; 2023 Feb; 31(2):159-172. PubMed ID: 36058786
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Hong J; Guo F; Lu SY; Shen C; Ma D; Zhang X; Xie Y; Yan T; Yu T; Sun T; Qian Y; Zhong M; Chen J; Peng Y; Wang C; Zhou X; Liu J; Liu Q; Ma X; Chen YX; Chen H; Fang JY
    Gut; 2021 Nov; 70(11):2123-2137. PubMed ID: 33318144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between
    Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
    World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles from
    Meng X; Ma G; Zhang X; Yin H; Miao Y; He F
    Cell Cycle; 2024 Feb; 23(3):294-307. PubMed ID: 38446489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study.
    Cuellar-Gómez H; Ocharán-Hernández ME; Calzada-Mendoza CC; Comoto-Santacruz DA
    Rev Gastroenterol Mex (Engl Ed); 2022; 87(3):277-284. PubMed ID: 34312118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis.
    Datorre JG; de Carvalho AC; Guimarães DP; Reis RM
    Pathobiology; 2021; 88(2):127-140. PubMed ID: 33291114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Performance of Intestinal
    Peng BJ; Cao CY; Li W; Zhou YJ; Zhang Y; Nie YQ; Cao YW; Li YY
    Chin Med J (Engl); 2018 Jun; 131(11):1349-1356. PubMed ID: 29786050
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
    Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Wang N; Zhang L; Leng XX; Xie YL; Kang ZR; Zhao LC; Song LH; Zhou CB; Fang JY
    Gut Microbes; 2024; 16(1):2333790. PubMed ID: 38533566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis.
    Ou S; Chen H; Wang H; Ye J; Liu H; Tao Y; Ran S; Mu X; Liu F; Zhu S; Luo K; Guan Z; Jin Y; Huang R; Song Y; Liu SL
    J Transl Med; 2023 Oct; 21(1):704. PubMed ID: 37814323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.